(Total Views: 514)
Posted On: 06/20/2025 6:37:02 AM
Post# of 154593
Well, as an experienced CYDY shareholder (onboard since 2017) I would say we will wait until Gilead or an other BP will have a marketable inferior product and then we quit LATCH after spending resources, time and money (government funds) for nothing.
Pretty much what we did with HIV PrEP.
It seems they are now following the same strategy for cancer ...
In the meantime we will post some useless posters in europe instead of starting trials which data would move the company and the SP forward.
They get more and more the same credibility as Dr. Kelly which told us for years about "partnerships".
btw. why did they not start with Alzheimer/ Dementia trial which was supposed to be fully funded by some good Samaritan? Did they not tell us this will start in Q1 2025 at one point?
Too many loose ends for my taste.
Now Dr. J proof me wrong and PR a substantial partnership. (not the Nader kind of "partnership"
Pretty much what we did with HIV PrEP.
It seems they are now following the same strategy for cancer ...
In the meantime we will post some useless posters in europe instead of starting trials which data would move the company and the SP forward.
They get more and more the same credibility as Dr. Kelly which told us for years about "partnerships".
btw. why did they not start with Alzheimer/ Dementia trial which was supposed to be fully funded by some good Samaritan? Did they not tell us this will start in Q1 2025 at one point?
Too many loose ends for my taste.
Now Dr. J proof me wrong and PR a substantial partnership. (not the Nader kind of "partnership"
(11)
(0)
